Trinity Biotech
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Trinity Biotech's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 24% to $56,832,000. The net income raised on -$24,018,000 and profit margin reached -42%. Total operating expenses were $46,495,000.

Profit Margin

Trinity Biotech plc (NASDAQ:TRIB): Profit margin
2014 104.87M 17.21M 16.41%
2015 100.19M 21.79M 21.75%
2016 99.61M -100.62M -101.02%
2017 99.14M -40.27M -40.62%
2018 97.03M 2.39M 2.46%
2019 90.43M -4.06M -4.5%
2020 101.98M -6.01M -5.9%
2021 92.96M 875K 0.94%
2022 74.77M -41.00M -54.83%
2023 56.83M -24.01M -42.26%

TRIB Income Statement (2014 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue
Revenue
56.83M74.77M92.96M101.98M90.43M97.03M99.14M99.61M100.19M104.87M
Cost of revenue
37.38M52.73M54.88M53.4M52.31M55.58M57.25M56.51M53.95M54.52M
Gross profit
19.45M22.04M38.07M48.58M38.12M41.44M41.88M43.09M46.24M50.34M
Operating exp.
Research and development
4.37M4.13M4.49M5.08M5.32M5.36M5.65M5.04M5.06M4.29M
Selling and marketing
00000032.24M000
Total operating expenses
46.49M32.96M24.51M28.29M32.81M34.76M36.41M35.60M32.79M32.30M
Operating income
-27.04M-10.91M13.15M19.10M872K3.29M5.47M7.49M13.44M18.03M
Other income (expenses), net
-9.88M-30.28M-12.40M-6.71M-51K-270K-2.20M-48.03M9.49M-35K
Income before tax
-36.92M-41.19M751K-6.63M821K3.02M1.60M5.19M22.87M18.06M
Income tax expense
-59K-192K-178K-620K4.88M637K-697K41K1.08M853K
Net income
-24.01M-41.00M875K-6.01M-4.06M2.39M-40.27M-100.62M21.79M17.21M
Earnings per share
Basic EPS
-3.14-6.080.2-1.44-0.970.57-9.31-21.910.960.76
Diluted EPS
-3.14-5.270.2-1.44-0.80.46-7.49-17.780.480.73
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source